ArticleParasites & vectors2025
A novel calreticulin of Psoroptes ovis regulated keratinocyte function resulting in host skin barrier dysfunction: implications for involvement in the pathogenesis of psoroptic mange.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundPsoroptes ovis, the causative agent of psoroptic mange, affects a wide range of domestic and wild animals, causing substantial economic losses and threatening wildlife survival. However, the underlying pathogenesis of this ectoparasitic disease remains poorly understood.
methodsIn this study, we comprehensively characterized the sequence conservation and excretory-secretory properties of P. ovis calreticulin (PsoCRT) using sequence alignment, immunoblotting, and immunofluorescence assays. To investigate the functional impact of recombinant PsoCRT (rPsoCRT), we conducted in vitro studies assessing its effects on keratinocyte proliferation, migration, differentiation, and the expression of immune regulatory factors. In addition, we employed rabbit ear intradermal injections of rPsoCRT to histologically observe tissue changes and confirm alterations in the expression profiles of immune regulatory factors.
resultsPsoCRT was expressed across all developmental stages of P. ovis, with peak expression observed in adult males. Notably, PsoCRT was excreted and secreted into the host epidermis, primarily localizing within the stratum granulosum and spinosum. Intriguingly, sera from rabbits infested with P. ovis did not recognize PsoCRT. In vitro studies revealed that rPsoCRT significantly inhibited keratinocyte proliferation and migration, promoted differentiation, and upregulated the expression of interleukin (IL)-1β, IL-6, IL-36, C-C motif chemokine ligand 27 (CCL27), and vascular endothelial growth factor (VEGF) in vitro, without altering the levels of interferon (IFN)-γ or tumor necrosis factor (TNF)-α. In vivo, rabbit ear intradermal injections of rPsoCRT induced epidermal cell differentiation, immune cell infiltration, and an upregulation of IL-6, CCL27, and VEGF expression.
conclusionsPsoCRT disrupted the physical and immune barriers of keratinocytes, leading to skin dysfunction and facilitating a microenvironment conducive to P. ovis parasitization, thereby highlighting its important role in the pathogenesis of psoroptic mange.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.